Evidence map›Paper›PMID 41688738›Full record

ArticleExperimental & molecular medicine2026

Spatiotemporal transcriptomic profiling reveals upregulation of glycolysis pathway genes before overt tauopathy in the PS19 mouse model.

Shuai Wang, Moorthi Ponnusamy, Om Patel, Mitchell Hansen, Lisa Collier, Shane Collier, Gopal Thinakaran

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shuai Wang *Byrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-9252-7496
Moorthi Ponnusamy *Byrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA.
Om PatelByrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA.
Mitchell HansenByrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA.
Lisa CollierByrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA.
Shane CollierByrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA.
Gopal ThinakaranByrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, USA. thinakaran@usf.edu.ORCID http://orcid.org/0000-0001-5523-6780

Funding

Cell autonomous and non-cell autonomous roles of the GWAS risk factor BIN1 in Alzheimer's disease neuropathologyRF1AG054223 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI THINAKARAN, GOPAL · 2016 to 2016
$2.9M
Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signalingRF1AG079141 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI RANGARAJU, SRIKANT, THINAKARAN, GOPAL · 2022 to 2022
$2.3M
The role of Alzheimer's disease GWAS risk factor BIN1 in tau neuropathology and propagation in vivoRF1AG077610 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI THINAKARAN, GOPAL · 2022 to 2022
$2.2M
Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signalingR01AG079141 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI Srikant Rangaraju, GOPAL THINAKARAN · 2025 to 2026
$1.4M
The role of Alzheimer's disease GWAS risk factor BIN1 in tau neuropathology and propagation in vivoR01AG077610 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI GOPAL THINAKARAN · 2025 to 2026
$1.4M
High-plex Protein and Gene Expression Digital Spatial Profiler for Core FacilityS10OD030346 · OD · UNIVERSITY OF SOUTH FLORIDA · PI THINAKARAN, GOPAL · 2021 to 2021
$450k
Alzheimer's Association AARF-61441339NIA NIH HHS R01 AG077610NIA NIH HHS R01 AG079141NIA NIH HHS RF1 AG054223NIA NIH HHS RF1 AG077610NIA NIH HHS RF1 AG079141NIH HHS S10 OD030346U.S. Department of Health & Human Services | Administration for Community Living (U.S. Department of Health and Human Services, Administration for Community Living) G077610U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD030346U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG054223
6 · The paper itself

Abstract

The abnormal accumulation of hyperphosphorylated tau in neurofibrillary tangles is a hallmark of neurodegenerative diseases, such as Alzheimer's disease (AD) and frontotemporal dementia. In AD, tangle pathology characteristically develops in brain regions with heightened vulnerability, such as the entorhinal cortex and hippocampus. Emerging evidence implicates mitochondrial dysfunction and metabolic disturbances in AD progression, yet the relationship between regional vulnerability and pretangle tau-driven transcriptomic changes remains unclear. Here, to address this critical gap, we utilized the tau P301S transgenic mouse model (PS19 line), which develops tau inclusions. Using spatial transcriptomic profiling across the hippocampal and cortical regions at selected disease stages, we captured spatiotemporal transcriptional responses to tauopathy. Our findings reveal that disease-associated microglia and astrocyte phenotypes emerge concurrently with phosphorylated tau accumulation across multiple brain regions. Intriguingly, the expression of Pgk1, a hub gene of the glycolytic pathway, was upregulated along with other metabolic pathway genes in the CA3 region at 2 months of age, preceding the onset of detectable tau tangle pathology, and correlated with tangle severity, suggesting early metabolic dysregulation in vulnerable regions. Further analysis of differentially expressed genes uncovered region-specific and temporally dynamic transcriptional patterns in the cortex and hippocampus. Early saturable alterations in ATP metabolic processes, glycolysis and oxidative phosphorylation appeared in the hippocampus at 2 months of age, with delayed engagement in the cortical regions. These results underscore the contributions of metabolic stress and glial activation to tauopathy and regional vulnerability, highlighting spatial transcriptomics as a powerful tool for uncovering region-specific molecular insights into disease mechanisms.

Indexed as

Gene Expression ProfilingGlycolysisTauopathiesTranscriptomeAnimalsDisease Models, AnimalHippocampusHumansMiceMice, TransgenicSpatial Transcriptomicstau ProteinsUp-Regulationtau Proteins

Identifiers

PMID41688738
PMCPMC12992590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.